|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.850 USD | -0.26% |
|
-13.87% | +14.24% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
| Market Cap | 635M 557M 515M 473M 895M 61.28B 908M 6.15B 2.41B 29.96B 2.39B 2.33B 103B | P/E 2026 * |
3.25x | P/E 2027 * | 3.12x |
|---|---|---|---|---|---|
| Enterprise Value | 635M 557M 515M 473M 895M 61.28B 908M 6.15B 2.41B 29.96B 2.39B 2.33B 103B | EV / Sales 2026 * |
1.38x | EV / Sales 2027 * | 1.33x |
| Free-Float |
96.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | -0.26% | ||
| 1 week | -13.87% | ||
| Current month | -8.55% | ||
| 1 month | +8.76% | ||
| 3 months | -13.09% | ||
| 6 months | -14.44% | ||
| Current year | +14.24% |
| 1 week | 3.8 |  | 4.23 |
| 1 month | 3.56 | | 4.88 |
| Current year | 2.95 | | 5.78 |
| 1 year | 0.72 | | 5.78 |
| 3 years | 0.53 | | 15.7 |
| 5 years | 0.53 | | 15.7 |
| 10 years | 0.53 | | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 11/03/2021 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 14/05/2026 |
Rosario Lobrutto
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 03/06/2021 |
Julie McHugh
CHM | Chairman | 61 | 31/03/2019 |
Marla Kessler
BRD | Director/Board Member | 56 | 31/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/07/26 | Sell | Chief Financial Officer | -127,890 | 0.0777% | ||
| 16/06/26 | Free | Chairman | 85,052 | 0.0517% | ||
| 16/06/26 | Free | Director | 63,481 | 0.0386% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | -13.87% | +401.63% | -63.26% | 635M | |
| -2.43% | +0.70% | +55.58% | +17.41% | 315B | |
| -0.99% | -3.40% | +22.02% | -9.46% | 67.81B | |
| -0.93% | +1.17% | +36.56% | +83.59% | 9.23B | |
| +0.34% | +0.51% | +5.21% | -1.87% | 8.56B | |
| -3.27% | -6.80% | -25.44% | -5.88% | 4.18B | |
| +0.12% | -11.96% | -7.91% | +16.33% | 3.59B | |
| -2.26% | +1.02% | -47.58% | +21.10% | 3.55B | |
| -1.29% | -2.15% | +46.63% | +56.40% | 2.79B | |
| +3.79% | +1.33% | +7.85% | -21.52% | 2.09B | |
| Average | -0.47% | -3.03% | +49.46% | +9.28% | 41.73B | |
| Weighted average by Cap. | -0.19% | +1.89% | +46.66% | +13.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 460M 403M 373M 343M 648M 44.37B 658M 4.45B 1.74B 21.69B 1.73B 1.69B 74.77B | 478M 419M 388M 356M 674M 46.13B 684M 4.63B 1.81B 22.55B 1.8B 1.76B 77.73B |
| Net income | 182M 159M 147M 135M 256M 17.51B 260M 1.76B 689M 8.56B 682M 667M 29.51B | 210M 184M 170M 156M 296M 20.24B 300M 2.03B 796M 9.89B 788M 771M 34.1B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$3.850 | -0.26% | 1,801,016 |
| 17/07/26 | US$3.860 | -0.26% | 1,803,987 |
| 16/07/26 | US$3.870 | -3.25% | 2,014,530 |
| 15/07/26 | US$4.000 | +0.50% | 1,366,536 |
| 14/07/26 | US$3.980 | -5.46% | 2,118,770 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
Select your edition
All financial news and data tailored to specific country editions
